Search

Author/Creator Ruth, M.

2. Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy. Issue 7 (19th February 2015)

Authors:
Shaheen, N. J.; Adler, J.; Dedrie, S.; Johnson, D.; Malfertheiner, P.; Miner, P.; Meulemans, A.; Poole, L.; Tack, J.; Thielemans, L.; Troy, S.; Vakil, N.; Zerbib, F.; Ruth, M.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 41:Issue 7(2015)
Page Start:
649
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Randomized clinical trial: effect of the 5‐HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment. Issue 2 (21st December 2014)

Authors:
Tack, J.; Zerbib, F.; Blondeau, K.; des Varannes, S. B.; Piessevaux, H.; Borovicka, J.; Mion, F.; Fox, M.; Bredenoord, A. J.; Louis, H.; Dedrie, S.; Hoppenbrouwers, M.; Meulemans, A.; Rykx, A.; Thielemans, L.; Ruth, M.
Journal:
Neurogastroenterology & motility
Issue:
Volume 27:Issue 2(2015:Feb.)
Page Start:
258
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗